- Home
- MVST vs GNFT Comparison
MVST vs GNFT Comparison
Compare MVST & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- GNFT
- Stock Information
- Founded
- MVST 2006
- GNFT 1999
- Country
- MVST United States
- GNFT France
- Employees
- MVST N/A
- GNFT N/A
- Industry
- MVST Industrial Machinery/Components
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MVST Miscellaneous
- GNFT Health Care
- Exchange
- MVST Nasdaq
- GNFT Nasdaq
- Market Cap
- MVST 182.8M
- GNFT 172.2M
- IPO Year
- MVST N/A
- GNFT 2019
- Fundamental
- Price
- MVST $2.18
- GNFT $3.60
- Analyst Decision
- MVST Buy
- GNFT Strong Buy
- Analyst Count
- MVST 3
- GNFT 1
- Target Price
- MVST $3.33
- GNFT $13.00
- AVG Volume (30 Days)
- MVST 17.5M
- GNFT 3.7K
- Earning Date
- MVST 11-12-2024
- GNFT 09-19-2024
- Dividend Yield
- MVST N/A
- GNFT N/A
- EPS Growth
- MVST N/A
- GNFT N/A
- EPS
- MVST N/A
- GNFT 0.47
- Revenue
- MVST $370,989,000.00
- GNFT $86,225,222.00
- Revenue This Year
- MVST $19.19
- GNFT $145.20
- Revenue Next Year
- MVST $29.35
- GNFT N/A
- P/E Ratio
- MVST N/A
- GNFT $7.51
- Revenue Growth
- MVST 39.03
- GNFT 175.45
- 52 Week Low
- MVST $0.15
- GNFT $3.35
- 52 Week High
- MVST $2.87
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- MVST 56.49
- GNFT 43.20
- Support Level
- MVST $1.92
- GNFT $3.47
- Resistance Level
- MVST $2.30
- GNFT $3.70
- Average True Range (ATR)
- MVST 0.28
- GNFT 0.10
- MACD
- MVST -0.06
- GNFT 0.04
- Stochastic Oscillator
- MVST 34.29
- GNFT 45.45
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extend from core battery chemistry to battery packs.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.